NEW YORK (dpa-AFX) – The possible preliminary out of the vaccinations with the active ingredient from Johnson & Johnson (JohnsonJohnson) (J&J) in the USA burdened the Dow Jones Industrial (Dow Jones 30 Industrial) on Tuesday. In early trading, it was down 0.39 percent to 33,615 points. In the US leading index, the shares of Johnson & Johnson (JohnsonJohnson) were among the biggest losers with minus two percent. The technology-heavy Nasdaq exchange, on the other hand, set new records.
In view of side effects, the responsible US authorities have recommended a temporary suspension of the corona vaccinations with the active ingredient from Johnson & Johnson. That could mean a serious setback for the country’s vaccination campaign, as the active ingredient – unlike the preparations from Pfizer / Biontech (BioNTech (ADRs)) and Moderna – only needs to be administered once and not twice.
The selection index NASDAQ 100, on the other hand, rose by 0.95 percent to 13,950 points and reached another record high. For the market-wide S&P 500 it went up 0.11 percent to 4132 points, also to a record high.
While Johnson & Johnson’s share price fell, the stocks of its competitors in the vaccine business Biontech and Pfizer were up 6.9 and 1.1 percent, respectively, while Moderna was up 8.7 percent.
At American Airlines, the news that the airline expects an adjusted loss of 2.8 billion US dollars for the first quarter caused a price slide of more than five percent./bek/he
–
TRADE FOREIGN EXCHANGE WITH UP TO LEVER 30 NOW
Trade forex with high leverage and small spreads. With just € 100 you can benefit from the effect of € 3,000 in capital.
–
76.4% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you can afford the high risk of losing your money.
–
– .
